Allergan Inc., the Irvine-based maker of Botox, eye drugs and other products, won a round in court last week in a patent battle over its Latisse eyelash grower. A federal appeals court in Washington, ...
On September 27, 2023, Judge Richard Andrews, following a three-day bench trial, determined that several patents asserted by Allergan against Sun Pharmaceuticals and MSN Laboratories were invalid for ...
In a highly anticipated decision in Allergan v. MSN Labs., the Federal Circuit held yesterday that claims in a first-filed, first-issued, later-expiring patent cannot be invalidated for double ...
A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...
U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...
An Illinois appellate court today affirmed a lower court's dismissal of a lawsuit involving the 2020 merger of North Chicago-based AbbVie and Irish drugmaker Allergan. Allergan shareholder Stephen ...
Facing new measures by the U.S. Treasury to thwart tax-evading deals, drugmaker Pfizer has officially jettisoned its $160 billion agreement to buy Allergan, according to published reports. Pfizer is ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN) today announced operating results for the quarter ended December 31, 2013. Allergan also announced that its Board of Directors has declared a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback